Detection of the neoplastic stomach lesions using ultrathin endoscope with the novel image enhanced endoscopy (IEE): A randomized controlled clinical trial.

Detection of the neoplastic stomach lesions using ultrathin endoscope with the novel image enhanced endoscopy (IEE): A randomized controlled clinical trial. - Detection of the neoplastic stomach lesions using ultrathin endoscope with the novel image enhanced endoscopy (IEE): A randomized controlled clinical trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026111

Enrollment

1500

Registered

2017-02-13

Start date

2017-02-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients who underwent upper gastrointestinal endoscopy.

Interventions

Image enhanced endoscopy (IEE) White ligth (Xenon)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - A person who undergo UGD endoscopy for the screening of the multi-focal cancer (synchronous / metachronous) - age ranged from 20 years to 80 years

Exclusion criteria

Exclusion criteria: - A person who is untolerable for a biopsy - A person who is unsuitable to undergo the procedure - A person who did not agree to participate.

Design outcomes

Primary

Measure	Time frame
Superiority in detectability of neoplastic stomach lesions using a novel IEE as compared to WLI.	—

Countries

Japan

Contacts

Public ContactToru Ito

Kanazawa Medical University Gastroenterological Endoscopy

itotohru@kanazawa-med.ac.jp076-286-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026